BackgroundBoth poor aerobic fitness and obesity, separately, are associated with
abnormal lipid profiles.ObjectiveTo identify possible relationships of dyslipidemia with cardiorespiratory
fitness and obesity, evaluated together, in children and adolescents.MethodsThis cross-sectional study included 1,243 children and adolescents (563 males
and 680 females) between 7 and 17 years of age from 19 schools. Obesity was
assessed using body mass index (BMI) measurements, and cardiorespiratory
fitness was determined via a 9-minute run/walk test. To analyze the lipid
profile of each subject, the following markers were used: total cholesterol,
cholesterol fractions (high-density lipoprotein and low-density lipoprotein)
and triglycerides. Data were analyzed using SPSS v. 20.0, via prevalence
ratio (PR), using the Poisson regression.ResultsDyslipidemia is more prevalent among unfit/overweight-obese children and
adolescents compared with fit/underweight-normal weight boys (PR: 1.25; p =
0.007) and girls (PR: 1.30, p = 0.001).ConclusionsThe prevalence of dyslipidemia is directly related to both obesity and lower
levels of cardiorespiratory fitness.
There is an association between the AA genotype of rs9939609 polymorphism and BMI among schoolchildren. The association between overweight/obesity in schoolchildren with a family history of obesity was found mainly among students with the AA genotype.
Objective: To identify tuberculosis-related health care and surveillance actions in Prison Health Units. Method: Cross-sectional study, of quantitative, exploratory and descriptive character. We visited 13 Teams of Prison Health, and nurses and technicians were interviewed regarding epidemiological surveillance instruments, physical structure and materials. Results: Search for respiratory symptoms in admission was reported by 6 (46.2%) of the teams, and the smear microscopy was the most requested test. The Logbook of Respiratory Symptoms and the Logbook for Monitoring Tuberculosis Cases were used in 7 (53.8%) institutions. Two of them (15.4%) had a location for sputum collection and 1 (7.7%) had a radiographer. The Directly Observed Therapy was reported in 7 (53.8%) units. Conclusion: Health care actions related to the search for respiratory symptoms and Directly Observed Therapy should be expanded, as well as surveillance actions and recording in official documents of the National Tuberculosis Control Program.
BackgroundWe investigated a potential link between genetic polymorphisms in genes XRCC1 (Arg399Gln), OGG1 (Ser326Cys), XRCC3 (Thr241Met), and XRCC4 (Ile401Thr) with the level of DNA damage and repair, accessed by comet and micronucleus test, in 51 COPD patients and 51 controls.MethodsPeripheral blood was used to perform the alkaline and neutral comet assay; and genetic polymorphisms by PCR/RFLP. To assess the susceptibility to exogenous DNA damage, the cells were treated with methyl methanesulphonate for 1-h or 3-h. After 3-h treatment the % residual damage was calculated assuming the value of 1-h treatment as 100%. The cytogenetic damage was evaluated by buccal micronucleus cytome assay (BMCyt).ResultsCOPD patients with the risk allele XRCC1 (Arg399Gln) and XRCC3 (Thr241Met) showed higher DNA damage by comet assay. The residual damage was higher for COPD with risk allele in the four genes. In COPD patients was showed negative correlation between BMCyt (binucleated, nuclear bud, condensed chromatin and karyorrhexic cells) with pulmonary function and some variant genotypes.ConclusionOur results suggest a possible association between variant genotypes in XRCC1 (Arg399Gln), OGG1 (Ser326Cys), XRCC3 (Thr241Met), and XRCC4 (Ile401Thr), DNA damage and progression of COPD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.